Archives for February 9, 2021

UK project looks to transform oligonucleotide medicines manufacturing

UK catalyst organization, CPI, has announced the launch of a project that aims to revolutionize the manufacture of oligonucleotides, through a collaboration involving, among others, AstraZeneca, Exactmer, and Novartis.

Clinical trial set to test efficacy of mixing Sputnik V and COVID-19 Vaccine AstraZeneca

Health officials in Azerbaijan have granted approval for a clinical trial to take place in that country combining Russia’s Sputnik V vaccine with the Oxford-AstraZeneca COVID-19 shot in adults 18 years and older.

Organ transplant patients can safely receive COVID-19 vaccine, suggests study

Johns Hopkins Medicine researchers have studied the reaction of nearly 200 solid organ transplant recipients to their first COVID-19 vaccine shot. The findings, they say, suggest that the Moderna and Pfizer/BioNTech mRNA vaccines can be safely given to...

Guest Article

What does Brexit mean for biopharma companies?

January 1, 2021 marked the UK’s official separation from the EU and with that has come a raft of changes to how the nation will now do business with the rest of the world.